Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
Status:
Completed
Trial end date:
2017-07-21
Target enrollment:
Participant gender:
Summary
The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical
Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear
pain.